NASDAQ: ASPE
Aspen Neuroscience Inc Earnings Dates, Reports, Calls

Aspen Neuroscience earnings were N/A for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest ASPE earnings report on Jun 30, 2026 announced Q2 2026 earnings of N/A, down N/A from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, ASPE reported annual earnings of -$62.1M, with 27.8% growth.

ASPE earnings history

Current Revenue
$0.0
Current Earnings
$0.0
Current Profit Margin
0%

ASPE Return on Equity

Insufficient data to display

ASPE Return on Assets

Insufficient data to display

Be the first to know when ASPE announces earnings.

ASPE Return on Capital Employed

Current Company
0%
Current Industry
-7.4%

ASPE vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
AARD-$69.51M-$69.89MN/A-$3.21
ABVC-$6.46M-$7.11MN/A-$0.29
ABVX-$285.22M-$460.11MN/A-$5.96
ACET-$89.96M-$98.97MN/A-$10.46
TRXBN/AN/AN/AN/A

Aspen Neuroscience Earnings Reports & History FAQ

What was ASPE's earnings growth in the past year?

As of Aspen Neuroscience's earnings date in Q4 2026, Aspen Neuroscience's earnings has grown year over year. ASPE earnings in the past year totalled N/A.

If you're new to stock investing, here's how to buy Aspen Neuroscience stock.

Is Aspen Neuroscience profitable or losing money?

As of the last Aspen Neuroscience earnings report, Aspen Neuroscience is currently losing money. Aspen Neuroscience's net profit (also called net income) for the twelve months ending Jun 30, 2026 was N/A, a N/A decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.